CRDL vs. ARKQ

Last updated Jun 3, 2026

CRDL (Cardiol Therapeutics Inc Class A) is a stock, while ARKQ (ARK Autonomous Technology & Robotics ETF) is Technology Equities fund actively managed by ARK. Over the past 5 years, CRDL returned -15.74%/yr vs 11.40%/yr for ARKQ. At a 0.30 correlation, their price movements are largely independent.

Performance

CRDL vs. ARKQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cardiol Therapeutics Inc Class A (CRDL) and ARK Autonomous Technology & Robotics ETF (ARKQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both investments are quite close, with CRDL having a 20.57% return and ARKQ slightly higher at 21.08%.

CRDL

• 1D: -5.74%
• 1M: -16.06%
• YTD: 20.57%
• 6M: 23.74%
• 1Y: -7.26%
• 3Y*: 19.84%
• 5Y*: -15.74%
• 10Y*: —

ARKQ

• 1D: -2.13%
• 1M: 8.33%
• YTD: 21.08%
• 6M: 23.88%
• 1Y: 72.69%
• 3Y*: 39.07%
• 5Y*: 11.40%
• 10Y*: 22.53%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRDL vs. ARKQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
CRDL Cardiol Therapeutics Inc Class A	20.57%	-25.48%	51.80%	65.33%	-72.43%	-15.14%	-38.35%	-5.49%
ARKQ ARK Autonomous Technology & Robotics ETF	21.08%	48.81%	33.88%	40.70%	-46.75%	1.74%	107.20%	17.36%

Correlation

The correlation between CRDL and ARKQ is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.35
Correlation (3Y) Calculated over the trailing 3-year period	0.28
Correlation (5Y) Calculated over the trailing 5-year period	0.34
Correlation (All Time) Calculated using the full available price history since Jan 16, 2019	0.30

Return for Risk

CRDL vs. ARKQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRDL

CRDL Risk / Return Rank: 36
CRDL Sharpe Ratio Rank: 36
CRDL Sortino Ratio Rank: 38
CRDL Omega Ratio Rank: 38
CRDL Calmar Ratio Rank: 34
CRDL Martin Ratio Rank: 35

ARKQ

ARKQ Risk / Return Rank: 62
ARKQ Sharpe Ratio Rank: 66
ARKQ Sortino Ratio Rank: 58
ARKQ Omega Ratio Rank: 54
ARKQ Calmar Ratio Rank: 70
ARKQ Martin Ratio Rank: 59

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRDL vs. ARKQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and ARK Autonomous Technology & Robotics ETF (ARKQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRDL	ARKQ	Difference
Sharpe ratio Return per unit of total volatility	-0.10	2.25	-2.35
Sortino ratio Return per unit of downside risk	0.37	2.79	-2.42
Omega ratio Gain probability vs. loss probability	1.04	1.34	-0.30
Calmar ratio Return relative to maximum drawdown	-0.20	3.55	-3.75
Martin ratio Return relative to average drawdown	-0.30	10.75	-11.05
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRDL vs. ARKQ - Sharpe Ratio Comparison

The current CRDL Sharpe Ratio is -0.10, which is lower than the ARKQ Sharpe Ratio of 2.25. The chart below compares the historical Sharpe Ratios of CRDL and ARKQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRDL	ARKQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.10	2.25	-2.35
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	0.36	-0.54
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.76	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.17	0.66	-0.83

Drawdowns

CRDL vs. ARKQ - Drawdown Comparison

The maximum CRDL drawdown since its inception was -92.71%, which is greater than ARKQ's maximum drawdown of -59.89%. Use the drawdown chart below to compare losses from any high point for CRDL and ARKQ.

Drawdown Indicators

	CRDL	ARKQ	Difference
Max Drawdown Largest peak-to-trough decline	-92.71%	-59.89%	-32.82%
Max Drawdown (1Y) Largest decline over 1 year	-39.87%	-20.58%	-19.29%
Max Drawdown (3Y) Largest decline over 3 years	-72.73%	-30.76%	-41.97%
Max Drawdown (5Y) Largest decline over 5 years	-90.72%	-55.71%	-35.01%
Max Drawdown (10Y) Largest decline over 10 years	—	-59.89%	—
Current Drawdown Current decline from peak	-81.42%	-3.47%	-77.95%
Average Drawdown Average peak-to-trough decline	-68.96%	-17.24%	-51.72%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.96%	6.78%	+20.18%

Volatility

CRDL vs. ARKQ - Volatility Comparison

Cardiol Therapeutics Inc Class A (CRDL) and ARK Autonomous Technology & Robotics ETF (ARKQ) have volatilities of 10.49% and 10.45%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRDL	ARKQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.49%	10.45%	+0.04%
Volatility (6M) Calculated over the trailing 6-month period	43.07%	24.44%	+18.63%
Volatility (1Y) Calculated over the trailing 1-year period	70.34%	32.49%	+37.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	87.04%	32.23%	+54.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	87.09%	29.84%	+57.25%

Dividends

CRDL vs. ARKQ - Dividend Comparison

CRDL has not paid dividends to shareholders, while ARKQ's dividend yield for the trailing twelve months is around 0.22%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARKQ ARK Autonomous Technology & Robotics ETF	0.22%	0.27%	0.00%	0.00%	0.00%	0.80%	0.86%	0.00%	2.86%	1.54%	0.00%	0.98%
CRDL Cardiol Therapeutics Inc Class A	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CRDL and ARKQ in my portfolio?

CRDL and ARKQ have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRDL or ARKQ?

CRDL has higher volatility (10.49%) compared to ARKQ (10.45%). In terms of maximum drawdown, CRDL dropped -92.71% vs ARKQ's -59.89%.

Which has better risk-adjusted returns?

ARKQ currently has the higher Sharpe Ratio (2.25 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.